glp 1 als Protective role of IGF-1 and GLP-1 signaling activation in neurological dysfunctions Full article: Targeting metabolic dysfunction

Then came the duals (like #tirzepatide), and even triagonists (#retatrutide) that pushed weight loss even farther

Yazens digital weight loss programme shows 61% GLP-1 adherence at 18 months highlighting the power of integrated medical and lifestyle support

Searching for semaglutide near you

More recent evidence is expanding their benefits to heart failure with preserved ejection fraction and clinically important renal outcomes in patients with and without diabetes

The majority of T2D management is in primary care, where clinicians (medical, nursing and pharmacist staff) play an important role in addressing patient needs and achieving treatment goals

This was a retrospective cohort study of adult patients with a body mass index (BMI)30kg/m2 prescribed GLP-1 analogue therapy at an obesity specialist clinic in Vancouver, Canada